Physician profile
Tyler John Back
NPI 1144704867
$2,104.39
in general payments reported to CMS, 2019-2025
30 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $368 · 2022: $702 · 2023: $224 · 2024: $438 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $419.43 | 2021-2024 | Xyosted, Nocdurna, Tlando |
| Coloplast Corp | $284.98 | 2021-2024 | Speedicath |
| Boston Scientific Corporation | $191.64 | 2021-2025 | Axonics |
| Karl Storz Endoscopy-America | $173.87 | 2024 | Hopkins |
| Olympus America INC. | $111.34 | 2022-2025 | Itind System |
| Astellas Pharma US INC | $108.13 | 2021-2025 | Xtandi |
| Dendreon Pharmaceuticals LLC | $96.47 | 2021-2025 | Provenge |
| Progenics Pharmaceuticals, INC. | $85.56 | 2022-2024 | Pylarify |
| Abbvie INC. | $78.73 | 2021-2025 | |
| Halozyme INC | $67.29 | 2023 | |
| Merck Sharp & Dohme LLC | $48.62 | 2021-2025 | Keytruda |
| Endo Pharmaceuticals INC. | $43.86 | 2022 | |
| Urogen Pharma, INC. | $39.65 | 2023-2025 | Jelmyto |
| Endo USA, INC. | $37.16 | 2024-2025 | Xiaflex, Aveed |
| Accord Healthcare, INC. | $31.35 | 2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $28.20 | 2025 | |
| Janssen Biotech, INC. | $26.97 | 2021 | |
| Medtronic, INC. | $26.38 | 2024 | Interstim |
| Teleflex LLC | $25.94 | 2025 | Barrigel |
| Laborie Medical Technologies Corp. | $21.41 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Photocure INC | $20.22 | 2023 | Cysview |
| Blue Earth Diagnostics | $20.03 | 2024 | |
| Immunitybio, INC. | $18.90 | 2025 | |
| Hollister Incorporated | $17.51 | 2021 | |
| 180 Medical, INC. | $15.52 | 2025 | |
| Axonics, INC. | $14.71 | 2021 | |
| Tolmar, INC. | $13.96 | 2024 | |
| Sumitomo Pharma America, INC. | $13.23 | 2024 | Gemtesa |
| Abc Home Medical Supply, INC. | $12.04 | 2022 | |
| Pfizer INC. | $11.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Back listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.